Comprehensive Mass Cytometry Analysis of Cell Cycle, Activation, and Coinhibitory Receptors Expression in CD4 T Cells from Healthy and HIV-Infected Individuals

Cytometry Part B - Clinical Cytometry

Volumn 92, Issue 1, 2017, Pages 21-32

  Corneau, Aurélien ^a,b   Cosma, Antonio ^c   Even, Sophie ^a   Katlama, Christine ^a,d   Le Grand, Roger ^c   Frachet, Véronique ^b   Blanc, Catherine ^a   Autran, Brigitte ^a,d  

^a SORBONNE UNIVERSITÉ   (France)

^b PSL RESEARCH UNIVERSITY   (France)

^c INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

activation; CD4 T cells; cell cycle; coinhibitory receptors; HIV; mass cytometry; resting cells

Indexed keywords

ANTIRETROVIRUS AGENT; CD27 ANTIGEN; CD28 ANTIGEN; CD38 ANTIGEN; CD45RA ANTIGEN; CHEMOKINE RECEPTOR CCR7; FAS ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; MONOCLONAL ANTIBODY; RETINOBLASTOMA PROTEIN;

ANTIGEN DETECTION; CD4+ T LYMPHOCYTE; CELL CYCLE; CELL DIFFERENTIATION; CRYOPRESERVATION; CYTOMETRY; ENZYME ACTIVATION; GENE EXPRESSION PROFILING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MASS CYTOMETRY; MEMORY CELL; MEMORY T LYMPHOCYTE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REVIEW; CYTOLOGY; FLOW CYTOMETRY; HIV INFECTIONS; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; PHYSIOLOGY; PROCEDURES; T LYMPHOCYTE SUBPOPULATION; VIROLOGY;

CD4-POSITIVE T-LYMPHOCYTES; CELL CYCLE; FLOW CYTOMETRY; HIV INFECTIONS; HUMANS; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTE SUBSETS;

EID: 85010843531     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.21502     Document Type: Review

References (34)

1. Bendall SC, Simonds EF, Qiu P, Amir el AD, Krutzik PO, Finck R, Bruggner RV, Melamed R, Trejo A, Ornatsky OI, et al. Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science 2011;332:687–696.
2. Bendall SC, Nolan GP. From single cells to deep phenotypes in cancer. Nat Biotechnol 2012;30:639–647.
3. Behbehani GK, Bendall SC, Clutter MR, Fantl WJ, Nolan GP. Single-cell mass cytometry adapted to measurements of the cell cycle. Cytometry Part A 2012;81A:552–566.
4. Ben-Sasson SZ, Gerstel R, Hu-Li J, Paul WE. Cell division is not a “clock” measuring acquisition of competence to produce IFN- or IL-4. J Immunol 2001;166:112–120.
5. Bird JJ, Brown DR, Mullen AC, Moskowitz NH, Mahowald MA, Sider JR, Gajewski TF, Wang CR, Reiner SL. Helper T-cell differentiation is controlled by the cell cycle. Immunity 1998;9:229–237.
6. Combadière B, Combadiere B, Blanc C, Li T, Carcelain G, Delaugerre C, Calvez V, Tubiana R, Debré P, Katlama C, et al. CD4+Ki67+ lymphocytes in HIV-infected patients are effector T cells accumulated in the G1 phase of the cell cycle. Eur J Immunol 2000;30:3598–3603.
7. de Masson A, Kirilovsky A, Zoorob R, Avettand-Fenoel V, Morin V, Oudin A, Descours B, Rouzioux C, Autran B. Blimp-1 overexpression is associated with low HIV-1 reservoir and transcription levels in central memory CD4+ T cells from elite controllers. AIDS 2014 Jul 17;28(11):1567–77. doi: 10.1097/QAD.0000000000000295.
8. Pogliaghi M, Lambert S, Assoumou L, Zoorob R, Papagno L, Lecardonnel F, Calvez V, Katlama C, Autran B, and the Eramune-01 study group. HIV reservoir changes in resting CD4 subsets in the IL7 plus ART intensification Eramune 01 study. Conference on Retroviruses and Opportunistic infections, 2014, Seattle USA. Abstract: # 977.
9. Pauken KE, Wherry EJ. Overcoming T cell exhaustion in infection and cancer. Trends Immunol 2015;36:265–276.
10. Attanasio J, Wherry EJ. Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease. Immunity 2016;44:1052–1068.
11. Chew GM, Fujita T, Webb GM, Burwitz BJ, Wu HL, Reed JS, Hammond KB, Clayton KL, Ishii N, Abdel-Mohsen M, et al. TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV Infection. PLoS Pathog 2016;12:e1005349.
12. Anderson AC, Joller N, Kuchroo VK. Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation. Immunity 2016;44:989–1004.
13. Moorman JP, Wang JM, Zhang Y, Ji XJ, Ma CJ, Wu XY, Jia ZS, Wang KS, Yao ZQ. Tim-3 Pathway Controls Regulatory and Effector T Cell Balance during Hepatitis C Virus Infection. J Immunol 2012;189:755–766.
14. Darzynkiewicz Z, Gong J, Juan G, Ardelt B, Traganos F. Cytometry of cyclin proteins. Cytometry 1996;25:1–13.
15. Jacobberger JW, Sramkoski RM, Stefan T. Multiparameter cell cycle analysis. Methods Mol Biol 2011;699:229–249.
16. Darzynkiewicz Z, Crissman H, Jacobberger JW. Cytometry of the cell cycle: Cycling through history. Cytometry Part A 2004;58A:21–32.
17. Richman DD, Margolis DM, Delaney M, Greene WC, Hazuda D, Pomerantz RJ. The challenge of finding a cure for HIV infection. Science 2009;323:1304–1307.
18. Towards an HIV cure: a global scientific strategy. International AIDS Society Scientific Working Group on HIV Cure, Deeks SG, Autran B, Berkhout B, Benkirane M, Cairns S, Chomont N, Chun TW, Churchill M, Di Mascio M, et al. Nat Rev Immunol 2012;12:607–614.
19. Katlama C, Deeks SG, Autran B, Martinez-Picado J, van Lunzen J, Rouzioux C, Miller M, Vella S, Schmitz JE, Ahlers J, et al. Barriers to a cure for HIV: New ways to target and eradicate HIV-1 reservoirs. Lancet 2013;381:2109–2117.
20. Maldarelli F, Wu X, Su L, Simonetti FR, Shao W, Hill S, Spindler J, Ferris AL, Mellors JW, Kearney MF, et al. HIV latency Specific HIV integration sites are linked to clonal expansion and persistence of infected cells. Science 2014;345:179–183.
21. Chomont N, El-Far M, Ancuta P, Trautmann L, Procopio FA, Yassine-Diab B, Boucher G, Boulassel MR, Ghattas G, Brenchley JM, et al. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med 2009;15:893–900.
22. Siliciano RF, Greene WC. HIV latency. Cold Spring Harb Perspect Med 2011;1:a007096.
23. Descours B, Avettand-Fenoel V, Blanc C, Samri A, Mélard A, Supervie V, Theodorou I, Carcelain G, Rouzioux C, Autran B, et al. Immune responses driven by protective human leukocyte antigen alleles from long-term nonprogressors are associated with low HIV reservoir in central memory CD4 T cells. Clin Infect Dis 2012;54:1495–1503.
24. Sáez-Cirión A, Bacchus C, Hocqueloux L, Avettand-Fenoel V, Girault I, Lecuroux C, Potard V, Versmisse P, Melard A, Prazuck T, et al. Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI Study. PLoS Pathog 2013;9:e1003211.
25. Bacchus C, Cheret A, Avettand-Fenoël V, Nembot G, Mélard A, Blanc C, Lascoux-Combe C, Slama L, Allegre T, Allavena C, et al. A single HIV-1 cluster and a skewed immune homeostasis drive the early spread of HIV among resting CD4+ cell subsets within one month post-infection. PLoS One 2013;8:e64219.
26. Lugli E, Gattinoni L, Roberto A, Mavilio D, Price DA, Restifo NP, Roederer M. Identification, isolation and in vitro expansion of human and nonhuman primate T stem cell memory cells. Nat Protoc 2013;8:33–42. doi: 10.1038/nprot.2012.143. Epub 2012 Dec 6.
27. Buzon MJ, Sun H, Li C, Shaw A, Seiss K, Ouyang Z, Martin-Gayo E, Leng J, Henrich TJ, Li JZ, Pereyra F, Zurakowski R, Walker BD, Rosenberg ES, Yu XG, Lichterfeld M, HIV-1 persistence in CD4+ T cells with stem cell-like properties. Nat Med 2014;20:139–142.
28. Perreau M, Savoye AL, De Crignis E, Corpataux JM, Cubas R, Haddad EK, De Leval L, Graziosi C, Pantaleo G. Follicular helper T cells serve as the major CD4 T cell compartment for HIV-1 infection, replication, and production. J Exp Med 2013;210:143–156.
29. Autran B, Murphy R, Costagliola D, Tubiana R, Clotet B, Gatell J, Staszewski S, Assoumou L, El-Habib R, Calvez V, et al. Greater viral rebound & reduced time to resume antretroviral therapy after therapeutic immunization with the ALVAC-HIV vaccine (vCP1452). AIDS 2008;22:1313–1322.
30. Cosma A, Nolan G, Gaudilliere B. Mass Cytometry: the time to settle down. Cytometry A 2017;91A:12–13.
31. Strauss-Albee D, Liang E, Ranganath T, Aziz N, Blish C. The newborn human NK cell repertoire is phenotypically formed but functionally reduced. Cytometry B Clin Cytom 2017;92B:33–41.
32. Abraham Y, Gerrits B, Rebhan M, Ludwig M-G, Gubser Keller C. Exploring glucocorticoid receptor agonists mechanism of action through mass cytometry and radial visualizations. Cytometry B Clin Cytom 2017;92B:42–56.
33. Vendrame E, Fukuyama J, Strauss-Albee D, Holmes S, Blish C. Mass cytometry analytical approaches reveal cytokine-induced changes in natural killer cells. Cytometry B Clin Cytom 2017;92B:57–67.
34. Leelatian N, Doxie DB, Greenplate AR, Mobley BC, Lehman JM, Sinnaeve J, Kauffmann RM, Werkhaven JA, Mistry AM, Weaver KD, et al. Single cell analysis of human tissues and solid tumors with mass cytometry. Cytometry B Clin Cytom 2017;92B:68–78.